January 2026, Volume 3, No. 1
Table of Contents

Letter from the Editors

Featured article

At a moment when surgical robotics is crowded with capital intensity and competing promises, Anne Osdoit has chosen a different path. As CEO of Moon Surgical, Partner at Sofinnova Partners, and leading the VC firm’s medtech accelerator, MD Start, as an investor and a seasoned company builder, Osdoit is redefining innovation by starting not with replacement, but with collaboration. Here, she reflects on her journey from biomedical engineer to repeat medtech CEO, the conviction behind Moon Surgical’s human-centered, AI-powered surgical robotics platform, and the leadership mindset required to build the future of robotics by keeping surgeons, patients, and reality firmly at the center.

Featured article

In Q4 2025, veteran operator, boardroom closer, and hands-on builder Ray Cohen quietly initiated and closed two substantial financings: $67 million for Spiro Medical and $50 million for Biobeat Medical, with no bankers, no finders, and no fanfare. Just conviction, access, and the trust of teams and investors who’ve seen him deliver again and again.

Need fresh inspiration for your medtech company as we navigate Q126? We’ve gathered insights from some of our LSI alumni thought leaders to help you stay ahead.

Celebrating recent leadership shifts and other announcements and accolades impacting our global LSI Alumni medtech community.

Select Medtech Industry Financings and Deals: December 2025, by Date Announced

Spotlighting capital partners who continue to drive innovation across medtech

Global demand for hernia repair mesh is accelerating due to an aging population and emerging product innovation. However, the market continues to face pricing pressure and legal turbulence, even as new materials and expanded coverage policies shape future adoption.

Pelvic floor repair mesh procedures are on the decline, driven by safety concerns and the rise of alternative treatment options. While global demand for incontinence treatment remains strong, mesh-based surgical repair has lost ground due to litigation, market exits, and shifting physician preferences.

Top medtech startups based on aggregated investor and industry interest from global executives using Compass Al for sourcing, and proprietary insights from our LSI USA, LSI Europe, and LSI Asia summits.

Every week, LSI’s Market Intelligence team tracks the signals shaping global medtech. December coverage highlighted three themes across the industry: early traction in endovascular robotics, renewed momentum in public market exits through a landmark Special Purpose Acquisition Company (SPAC) merger, and strategic positioning around robotic control of transcatheter procedures. Taken together, the numbers point to a market increasingly shaped by platform leverage, capital efficiency, and access to large procedural volumes.

Neurostimulation Procedure Volumes, by Country, 2024–2030

Intracranial vs. Extracranial SRS Procedures, by Country, 2024–2030

AiM Medical Robotics is bringing real-time MRI guidance and robotic precision together to solve one of neurosurgery’s most persistent challenges: hitting delicate brain targets accurately despite tissue motion. Led by Co-Founder and CEO Gregory Fischer, the company is preparing for first-in-human trials that could reshape how stereotactic neurosurgery is performed.

Celebrating the accomplishments of a few of the many bright stars in our LSI presenting company and speaker alumni community.

This month, we’re showcasing technologies and organizations impacting our industry and patient lives.

Trusted By The Companies Pioneering What’s Next

Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.